Net Cash Provided by (Used in) Operating Activities |
1.6M |
USD |
+1.18% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-157K |
USD |
-1393% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-852K |
USD |
+61.3% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
200K |
shares |
0% |
Q4 2023 |
FY 2023 |
Common Stock, Shares, Issued |
185K |
shares |
0% |
Q4 2023 |
FY 2023 |
Common Stock, Par or Stated Value Per Share |
0.5 |
USD/shares |
0% |
Q4 2023 |
FY 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
595K |
USD |
|
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
5.22M |
USD |
-28.5% |
Q4 2023 |
FY 2023 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
13K |
USD |
-8.61% |
Q1 2024 |
Q1 2024 |
Depreciation |
19K |
USD |
+4.51% |
Q1 2024 |
Q1 2024 |
Property, Plant and Equipment, Gross |
350K |
USD |
-51.8% |
Q2 2024 |
Q2 2024 |
Deferred Income Tax Expense (Benefit) |
36.9K |
USD |
-68% |
Q2 2024 |
Q2 2024 |
Current Income Tax Expense (Benefit) |
279K |
USD |
-48.5% |
Q2 2024 |
Q2 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
2.16M |
USD |
+28.9% |
Q4 2023 |
FY 2023 |
Interest Expense |
67.8K |
USD |
+31.6% |
Q1 2024 |
Q1 2024 |